Randomised study of the immunomodulatory effects of azithromycin in severely asthmatic horses.
Abstract: Neutrophilic inflammation is believed to contribute to the airway obstruction and remodelling in equine asthma. Azithromycin, an antibiotic with immunomodulatory properties, reduces pulmonary neutrophilia and hyper-responsiveness in human asthmatics and decreases airway remodelling in rodent models of asthma. It was therefore hypothesised that azithromycin would improve lung function, mucus accumulation and central airway remodelling by decreasing luminal neutrophilia in severe equine asthma. The effects of a 10-day treatment with either azithromycin or ceftiofur, an antimicrobial without immune-modulating activity, were assessed using a blind, randomised, crossover design with six severe asthmatic horses in clinical exacerbation. Lung function, tracheal mucus accumulation, tracheal wash bacteriology, bronchial remodelling, airway neutrophilia and mRNA expression of proinflammatory cytokines (interleukin (IL)-8, IL-17A, IL-1β, tumour necrosis factor-α) in bronchoalveolar lavage fluid were evaluated. Azithromycin decreased the expression of IL-8 (P=0.03, one-tailed) and IL-1β (P=0.047, one-tailed) but failed to improve the other variables evaluated. Ceftiofur had no effect on any parameter. The reduction of neutrophilic chemoattractants (IL-8, IL-1β) justifies further efforts to investigate the effects of a prolonged treatment with macrolides on airway neutrophilia and remodelling. The lack of efficacy of ceftiofur suggests that severe equine asthma should not be treated with antibiotics at first-line therapy.
© British Veterinary Association 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Publication Date: 2019-08-03 PubMed ID: 31371681DOI: 10.1136/vr.105260Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Randomized Controlled Trial
- Veterinary
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The study used a randomised trial to investigate the effects of azithromycin, an antibiotic with immune-modulating properties, on severely asthmatic horses with hopes of improving lung function and decreasing elements of inflammation and remodelling.
Research Background and Hypothesis
- This research is based on the understanding that neutrophilic inflammation is a significant factor in airway obstruction and remodelling related to equine asthma.
- Azithromycin, an antibiotic, has shown immunomodulatory properties, such as reducing pulmonary neutrophilia, hyper-responsiveness in human asthma patients, and airway remodelling in rodent models with asthma. As a result, the study hypothesized that azithromycin could have similar effect on improving lung function, reducing mucus accumulation, and decreasing neutrophilia (a type of inflammation) in severe equine asthma.
Study Design and Methods
- The researchers used a blind, randomised, and crossover design for this study, and the effects of azithromycin were compared with ceftiofur, an antimicrobial that lacks immunomodulating capacity.
- They used six severe asthmatic horses during their clinical exacerbation and administered a 10-day treatment with either azithromycin or ceftiofur.
- They evaluated several variables including lung function, tracheal mucus accumulation, tracheal wash bacteriology, bronchial remodelling, airway neutrophilia, and the mRNA expression of proinflammatory cytokines in bronchoalveolar lavage fluid.
Study Findings
- While the treatment with azithromycin resulted in the decreased expression of IL-8 and IL-1β (proinflammatory cytokines), it didn’t improve other evaluated parameters.
- Ceftiofur, the comparison drug, had no effect on any parameter, suggesting that its use as a first-line treatment for severe equine asthma may not be effective.
Conclusion and Further Directions
- The observed reduction of neutrophilic chemoattractants with azithromycin justifies further investigations into the effects of prolonged treatment with macrolides on airway neutrophilia and remodelling.
- The researchers concluded that severe equine asthma should perhaps not be initially treated with antibiotics given their failure to affect any of the evaluated parameters.
Cite This Article
APA
Mainguy-Seers S, Vargas A, Labrecque O, Bédard C, Hélie P, Lavoie JP.
(2019).
Randomised study of the immunomodulatory effects of azithromycin in severely asthmatic horses.
Vet Rec, 185(5), 143.
https://doi.org/10.1136/vr.105260 Publication
Researcher Affiliations
- Faculty of Veterinary Medicine, Department of Clinical Sciences, Université de Montréal, St-Hyacinthe, Q, Canada.
- Faculty of Veterinary Medicine, Department of Clinical Sciences, Université de Montréal, St-Hyacinthe, Q, Canada.
- Laboratoire d'epidemiosurveillance animale du Q, Saint-Hyacinthe, Q, Canada.
- Faculty of Veterinary Medicine, Department of Pathology and Microbiology, Université de Montréal, St-Hyacinthe, Q, Canada.
- Faculty of Veterinary Medicine, Department of Pathology and Microbiology, Université de Montréal, St-Hyacinthe, Q, Canada.
- Faculty of Veterinary Medicine, Department of Clinical Sciences, Université de Montréal, St-Hyacinthe, Q, Canada Jean-pierre.lavoie@umontreal.ca.
MeSH Terms
- Airway Remodeling / drug effects
- Animals
- Asthma / drug therapy
- Asthma / veterinary
- Azithromycin / pharmacology
- Cross-Over Studies
- Female
- Horse Diseases / drug therapy
- Horses
- Immunologic Factors / pharmacology
- Inflammation / drug therapy
- Inflammation / veterinary
- Lung / drug effects
- Lung / immunology
- Lung / physiology
- Male
- Mucus / drug effects
- Mucus / physiology
- Respiratory Function Tests / veterinary
- Trachea / drug effects
- Trachea / microbiology
- Trachea / physiology
Conflict of Interest Statement
Competing interests: None declared.
Citations
This article has been cited 7 times.- Dugot M, Merzon E, Ashkenazi S, Vinker S, Green I, Golan-Cohen A, Israel A. The Association between Previous Antibiotic Consumption and SARS-CoV-2 Infection: A Population-Based Case-Control Study. Antibiotics (Basel) 2023 Mar 15;12(3).
- Wu S, Tian X, Mao Q, Peng C. Azithromycin attenuates wheezing after pulmonary inflammation through inhibiting histone H3K27me3 hypermethylation mediated by EZH2. Clin Epigenetics 2023 Jan 23;15(1):12.
- Blondeau JM. Immunomodulatory Effects of Macrolides Considering Evidence from Human and Veterinary Medicine. Microorganisms 2022 Dec 9;10(12).
- Rutledge JJ, Paegelow J, Ritchey J, Singh A, Rizzi T, Murray C, Gilliam L, Crisman E, Williams NJ, Holbrook TC. Nebulized glycosylated caffeic acid phenylether ester attenuation of environmental particulate-induced airway inflammation in horses. Front Vet Sci 2022;9:958567.
- Mainguy-Seers S, Boivin R, Pourali Dogaheh S, Beaudry F, Hélie P, Bonilla AG, Martin JG, Lavoie JP. Effects of azithromycin on bronchial remodeling in the natural model of severe neutrophilic asthma in horses. Sci Rep 2022 Jan 10;12(1):446.
- Symoens A, Westerfeld R, Vives BM, André V, Moulon L, Collomb M, Richard H, Juette T, Bédard C, Leclère M. Steamed hay and alfalfa pellets for the management of severe equine asthma. Equine Vet J 2025 May;57(3):756-765.
- van den Brom-Spierenburg AJ, Mureșan AN, Westermann CM. Antimicrobial Prescription Behavior in Equine Asthma Cases: An International Survey. Animals (Basel) 2024 Jan 30;14(3).
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists